Work

A novel phase I trial design featuring a two-dimensional dose-finding algorithm optimizing the dose of gemcitabine and doxorubicin with bortezomib in metastatic urothelial carcinoma (UC).

Year: 2013

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2013.31.15_suppl.4548

Authors: Arlene O. Siefker-Radtke, Sijin Wen, Yu Shen, Kristi Stigall, David James McConkey, Randall E. Millikan

Institutions: The University of Texas MD Anderson Cancer Center, West Virginia University, Essentia Health

Language: English

Topic: Bladder and Urothelial Cancer Treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2589668105

Cites:

Cited by: 1

Related to: 10